Letiembre et al. offered the first evidence for a role of the key innate immune receptor TLR4 in neuroinflammation in AD by demonstrating that TLR4 contributes to Aβ peptide-induced microglial neurotoxicity (104). The gene discussed is TLR4; the disease is Alzheimer disease.